In 1935 was created Invesco, which is appeared as VC. The main department of described VC is located in the Atlanta. The venture was found in North America in United States.
The overall number of key employees were 1.
The average startup value when the investment from Invesco is 100-500 millions dollars. The increased amount of exits for fund were in 2013. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2005. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this Invesco works on 1 percentage points more the average amount of lead investments.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Invesco, startups are often financed by Accel, Imperial Innovations, IP Group Plc. The meaningful sponsors for the fund in investment in the same round are Accel, Sequoia Capital, Lansdowne Partners. In the next rounds fund is usually obtained by Woodford Investment Management, Accel, Imperial Innovations.
We can highlight the next thriving fund investment areas, such as Telecommunications, Semiconductor. Among the most popular portfolio startups of the fund, we may highlight Oxford Nanopore Technologies, Cell Medica, Thin Film Electronics. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aii Corporation Oy | - |
| Altria | Richmond, United States, Virginia |
| Baoxin Venture Capital | China, Zhejiang, Zhoushan |
| Beacon Capital | New York, New York, United States |
| BrahmaX Ventures | Calabasas, California, United States |
| Comdata | Italy, Lombardia, Milano |
| Crestview Partners | New York, New York, United States |
| DigitalDx Ventures | California, San Francisco, United States |
| FireEye | California, Milpitas, United States |
| GC Capital | New York, New York, United States |
| LONGHOO | China, Jiangsu, Nanjing |
| Murphy Family Ventures | - |
| purple patch venture | - |
| Shenzhen Zhongrun Ruitai Investment Management | China, Guangdong, Shenzhen |
| Thoobik Holdings | - |
| Ticonderoga Capital | Braintree, Massachusetts, United States |
| Times Mirror Interactive | California, Los Angeles, United States |
| Yijin Investment | China, Wenzhou, Zhejiang |
| Yinsheng Chuangxin Touzi | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Capchase | $80M | 10 Mar 2022 | New York, New York, United States | ||
Brii Biosciences | $155M | 23 Mar 2021 | San Francisco, California, United States | ||
Hello Alfred | $40M | 31 May 2018 | New York, New York, United States | ||
T She Dingzhi | $1M | 09 Feb 2018 | Siming, China | ||
Lamellar Biomedical | $7M | 08 May 2017 | United Kingdom, Scotland, United Kingdom | ||
Psioxus Therapeutics | $34M | 19 May 2015 | United Kingdom, England | ||
SciFluor Life Sciences | $30M | 21 Apr 2015 | Boston, Massachusetts, United States | ||
Genomics | $16M | 26 Nov 2014 | Oxford, England, United Kingdom | ||
Kuur Therapeutics | $68M | 25 Nov 2014 | United Kingdom, England |
– Pine Labs, a merchant commerce platform, raised $100m funding.
– The round was led by Invesco Developing Markets Fund.
– The startup is looking to file for an initial public offering within two years.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Capchase | $80M | 10 Mar 2022 | New York, New York, United States | ||
Brii Biosciences | $155M | 23 Mar 2021 | San Francisco, California, United States | ||
Hello Alfred | $40M | 31 May 2018 | New York, New York, United States | ||
T She Dingzhi | $1M | 09 Feb 2018 | Siming, China | ||
Lamellar Biomedical | $7M | 08 May 2017 | United Kingdom, Scotland, United Kingdom | ||
Psioxus Therapeutics | $34M | 19 May 2015 | United Kingdom, England | ||
SciFluor Life Sciences | $30M | 21 Apr 2015 | Boston, Massachusetts, United States | ||
Genomics | $16M | 26 Nov 2014 | Oxford, England, United Kingdom | ||
Kuur Therapeutics | $68M | 25 Nov 2014 | United Kingdom, England |
